Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

Immunomic Therapeutics, Inc. ("Immunomic Therapeutics"), a company developing next-generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. ("Astellas") today announced they have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax, Immunomic Therapeutics' vaccine designed to treat allergies induced by Japanese red cedar pollen.

30 Jan 2015

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.

29 Jan 2015

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

Magnus Life Science is today celebrating its unique collaboration with University College London (UCL), one of the world's leading universities, to advance bio-medical research and bring real innovation to areas of high unmet medical need.

29 Jan 2015

Scientists publish catalog of genetic mutations found in head and neck cancers

Scientists have published the first comprehensive catalog of genetic mutations and other abnormal changes found in 279 cancers of the head and neck, and have identified several broken molecular pathways that might be targeted by existing and future cancer drugs.

28 Jan 2015

GW Cancer Institute selected to study health disparities in cancer care

The George Washington University Cancer Institute received a $97K grant from Genentech to address health disparities in cancer care.

28 Jan 2015

Alectinib active against leptomeningeal metastases in ALK-positive NSCLC

Patients with anaplastic lymphoma kinase-rearranged non-small-cell lung cancer who have leptomeningeal metastases may benefit from treatment with the second-generation ALK inhibitor alectinib, a case series suggests.

28 Jan 2015

Plasma EGFR mutation cfDNA predicts advanced lung cancer outcome

Monitoring plasma cell-free DNA levels of epidermal growth factor receptor mutations may indicate prognosis for patients with lung adenocarcinoma after EGFR–tyrosine kinase inhibitor therapy, research suggests.

28 Jan 2015

SRS fails to improve survival for NSCLC brain metastases patients

Phase III trial findings suggest that carrying out stereotactic radiosurgery before chemotherapy does not improve overall survival for non-small-cell lung cancer patients with asymptomatic brain metastases compared with chemotherapy alone.

28 Jan 2015

Study shows that some older women with breast cancer could avoid radiotherapy

Some older women with breast cancer could safely avoid radiotherapy, without harming their chances of survival, a study has shown.

28 Jan 2015

SCCA's Fred Hutch Bone Marrow Transplant Program achieves higher survival rates

The Fred Hutchinson Cancer Research Center Bone Marrow Transplant Program at Seattle Cancer Care Alliance was recently recognized for outperforming its anticipated one-year survival rate for allogeneic transplant patients.

28 Jan 2015

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

A new range of vitamins and food supplements developed to enhance the health of specific organs has been launched in the UK.

28 Jan 2015

Researchers explore KRAS pathway to find potential target for treating lung cancer

Despite the promise of the gene KRAS as a target for treating lung cancer, finding effective therapies has been challenging. Now researchers are traveling down the pathway to find what makes KRAS cancerous.

28 Jan 2015

Study finds that African-American people with colon cancer have lower survival rates

African-American people diagnosed with colon cancer have consistently lower survival rates compared with white patients, despite a nationwide decline in colon cancer deaths overall.

28 Jan 2015

Mayo Clinic study compares new breast cancer risk prediction model with current model

A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard.

27 Jan 2015

BRCA1/2 analysis: an interview with Jurgi Camblong, CEO of Sophia Genetics

BRCA1 and BRCA2 genes are two of the most well studied genes in the cancer field. They are tumor suppressors - mutations in these genes can lead to breast and/or ovarian cancer. Predispositions can be detected in women before they develop cancer.

26 Jan 2015

NMR in cancer research: an interview with Andy Byrd

My research these days is generally classified as structural biology, although as I trained in chemistry. I specialize in nuclear magnetic resonance (NMR) applied to biological problems. Our lab is very interested in studying mammalian proteins, particularly systems involved in cancer, in order to try to understand mechanisms to provide that information for our collaborators, and for the general knowledge of the community as well.

From Bruker BioSpin Group 26 Jan 2015

Bayer, MD Anderson partner to evaluate how a drug may affect patient's disease-related symptoms

When cancer patients take part in a clinical trial to develop new therapies, they and their physicians want to know how they will feel and function during treatment. A new collaboration between Bayer and The University of Texas MD Anderson Cancer Center will go straight to the patients to learn how certain investigational new drugs affect them.

24 Jan 2015

Gem Pharmaceuticals enrolls initial soft tissue sarcoma patients in GPX-150 Phase 2 clinical trial

Gem Pharmaceuticals announced today that the initial soft tissue sarcoma (STS) patients have been enrolled into the Company's Phase 2 clinical trial. This open-label study will assess the efficacy and safety of Gem's lead compound, GPX-150 (an investigational medication), in approximately 30 adults as first-line therapy for advanced or metastatic disease.

23 Jan 2015

Colorectal cancer incidence increasing among young adults

The incidence of colorectal cancer (CRC) among young adults ages 20-39 years has increased during the past 20-30 years, despite declining rates of CRC for the U.S. population overall.

23 Jan 2015

Gensignia's research in CT lung cancer screening recognized by ASCO

Gensignia scientific co-founders' research has been recognized in Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology published online in the Journal of Clinical Oncology (JCO) on January 20, 2015.

22 Jan 2015

Oncology News and Research

Further Reading

Immunomic Therapeutics, Astellas Pharma sign license deal to develop LAMP-vax DNA vaccines

EKF Molecular Diagnostics collaborates with ANGLE for liquid biopsy development using Parsortix and PointMan technologies

Magnus Life Science commemorates unique partnership with UCL to advance bio-medical research

Scientists publish catalog of genetic mutations found in head and neck cancers

GW Cancer Institute selected to study health disparities in cancer care

Alectinib active against leptomeningeal metastases in ALK-positive NSCLC

Plasma EGFR mutation cfDNA predicts advanced lung cancer outcome

SRS fails to improve survival for NSCLC brain metastases patients

Study shows that some older women with breast cancer could avoid radiotherapy

SCCA's Fred Hutch Bone Marrow Transplant Program achieves higher survival rates

ProfBiotics develops evidence-based health supplements to enhance health, wellbeing

Researchers explore KRAS pathway to find potential target for treating lung cancer

Study finds that African-American people with colon cancer have lower survival rates

Mayo Clinic study compares new breast cancer risk prediction model with current model

BRCA1/2 analysis: an interview with Jurgi Camblong, CEO of Sophia Genetics

NMR in cancer research: an interview with Andy Byrd

Bayer, MD Anderson partner to evaluate how a drug may affect patient's disease-related symptoms

Gem Pharmaceuticals enrolls initial soft tissue sarcoma patients in GPX-150 Phase 2 clinical trial

Colorectal cancer incidence increasing among young adults

Gensignia's research in CT lung cancer screening recognized by ASCO

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News